☰

Amy Claxton, Ph.D. - Publications

Affiliations: 
2010 Psychology University of Massachusetts, Amherst, Amherst, MA 
Area:
Clinical Psychology, Individual and Family Studies, Ethnic and Racial Studies
Tree Info Grants Similar researchers PubMed Report error

19 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Lauriello J, Claxton A, Du Y, Weiden PJ. Beyond 52-Week Long-Term Safety: Long-Term Outcomes of Aripiprazole Lauroxil for Patients With Schizophrenia Continuing in an Extension Study. The Journal of Clinical Psychiatry. 81. PMID 32841554 DOI: 10.4088/Jcp.19M12835  0.303
2020 Craft S, Tripputi M, Edelstein S, Espeland M, Claxton A, Arslanian SA, Barengolts E, Hannon TS, Kahn SE, Mather KJ, Mokhlesi B, Nadeau KJ, Sanderlin A, Temple KA, Zeitler P. 1268-P: Associations between ß-Cell Function and Cognitive Measures following Treatment in Youth with Impaired Glucose Tolerance (IGT) or Recently Diagnosed Type 2 Diabetes (T2D) Diabetes. 69. DOI: 10.2337/Db20-1268-P  0.322
2019 Weiden PJ, Claxton A, Du Y, Lauriello J. 63 Long-term Outcomes with Aripiprazole Lauroxil for the Treatment of Schizophrenia: A 2-Year, Phase 3, Multicenter Extension Study. Cns Spectrums. 24: 208-209. PMID 30859984 DOI: 10.1017/S109285291900049X  0.304
2019 Miller BJ, Claxton A, Du Y, Weiden PJ, Potkin SG. Switching patients with schizophrenia from paliperidone palmitate to aripiprazole lauroxil: A 6-month, prospective, open-label study. Schizophrenia Research. PMID 30745067 DOI: 10.1016/J.Schres.2019.01.038  0.314
2019 Craft S, Claxton A, Tripputi M, Edelstein S, Arslanian SA, Temple KA, Nadeau KJ, Sanderlin A, Espeland M, Mokhlesi B, Mather KJ, Zeitler P. 1561-P: Associations between ß-Cell Function and Cognitive Measures Differ in Youth vs. Adults with Impaired Glucose Tolerance (IGT) or Early Type 2 Diabetes (T2D) Diabetes. 68. DOI: 10.2337/Db19-1561-P  0.303
2017 Craft S, Claxton A, Baker LD, Hanson AJ, Cholerton B, Trittschuh EH, Dahl D, Caulder E, Neth B, Montine TJ, Jung Y, Maldjian J, Whitlow C, Friedman S. Effects of Regular and Long-Acting Insulin on Cognition and Alzheimer's Disease Biomarkers: A Pilot Clinical Trial. Journal of Alzheimer's Disease : Jad. PMID 28372335 DOI: 10.3233/Jad-161256  0.31
2015 Claxton A, Baker LD, Hanson A, Trittschuh EH, Cholerton B, Morgan A, Callaghan M, Arbuckle M, Behl C, Craft S. Long-acting intranasal insulin detemir improves cognition for adults with mild cognitive impairment or early-stage Alzheimer's disease dementia. Journal of Alzheimer's Disease : Jad. 44: 897-906. PMID 25374101 DOI: 10.3233/Jad-141791  0.325
2013 Claxton A, Baker LD, Wilkinson CW, Trittschuh EH, Chapman D, Watson GS, Cholerton B, Plymate SR, Arbuckle M, Craft S. Sex and ApoE genotype differences in treatment response to two doses of intranasal insulin in adults with mild cognitive impairment or Alzheimer's disease. Journal of Alzheimer's Disease : Jad. 35: 789-97. PMID 23507773 DOI: 10.3233/Jad-122308  0.332
2013 Claxton A, Baker L, Hanson A, Cholerton B, Trittschuh E, Morgan A, Callaghan M, Arbuckle M, Behl C, Craft S. Long-acting intranasal insulin detemir improves working memory for adults with mild cognitive impairment or early-stage Alzheimer's dementia Alzheimers & Dementia. 9: 657. DOI: 10.1016/J.Jalz.2013.05.1350  0.312
2012 Craft S, Baker LD, Montine TJ, Minoshima S, Watson GS, Claxton A, Arbuckle M, Callaghan M, Tsai E, Plymate SR, Green PS, Leverenz J, Cross D, Gerton B. Intranasal insulin therapy for Alzheimer disease and amnestic mild cognitive impairment: a pilot clinical trial. Archives of Neurology. 69: 29-38. PMID 21911655 DOI: 10.1001/Archneurol.2011.233  0.332
2012 Claxton A, O'Rourke N, Smith JZ, DeLongis A. Personality traits and marital satisfaction within enduring relationships: An intra-couple discrepancy approach Journal of Social and Personal Relationships. 29: 375-396. DOI: 10.1177/0265407511431183  0.326
2011 O'Rourke N, Claxton A, Chou PH, Smith JZ, Hadjistavropoulos T. Personality trait levels within older couples and between-spouse trait differences as predictors of marital satisfaction. Aging & Mental Health. 15: 344-53. PMID 21491219 DOI: 10.1080/13607863.2010.519324  0.355
2011 O'Rourke N, Cappeliez P, Claxton A. Functions of reminiscence and the psychological well-being of young-old and older adults over time. Aging & Mental Health. 15: 272-81. PMID 21140308 DOI: 10.1080/13607861003713281  0.309
2011 O'Rourke N, Claxton A, Kupferschmidt AL, Smith JZ, Beattie BL. Marital idealization as an enduring buffer to distress among spouses of persons with Alzheimer disease Journal of Social and Personal Relationships. 28: 117-133. DOI: 10.1177/0265407510386135  0.332
2011 Perry-Jenkins M, Claxton A. The transition to parenthood and the reasons "Momma ain't happy" Journal of Marriage and Family. 73: 23-28. DOI: 10.1111/J.1741-3737.2010.00785.X  0.608
2010 O'Rourke N, Kupferschmidt AL, Claxton A, Smith JZ, Chappell N, Beattie BL. Psychological resilience predicts depressive symptoms among spouses of persons with Alzheimer disease over time. Aging & Mental Health. 14: 984-93. PMID 21069604 DOI: 10.1080/13607863.2010.501063  0.302
2010 O'Rourke N, Neufeld E, Claxton A, Smith JZ. Knowing me-knowing you: Reported personality and trait discrepancies as predictors of marital idealization between long-wed spouses. Psychology and Aging. 25: 412-21. PMID 20545425 DOI: 10.1037/A0017873  0.325
2009 Perry-Jenkins M, Claxton A. Feminist visions for rethinking work and family connections Handbook of Feminist Family Studies. 121-133. DOI: 10.4135/9781412982801.n10  0.547
2008 Claxton A, Perry-Jenkins M. No Fun Anymore: Leisure and Marital Quality Across the Transition to Parenthood. Journal of Marriage and the Family. 70: 28-43. PMID 20224746 DOI: 10.1111/J.1741-3737.2007.00459.X  0.603
Show low-probability matches.